Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$34.50 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles The Small Business Innovation Research Program: An Assessment of the Department of Defense Fast Track Initiative An Assessment of the SBIR Program Other Related Titles Venture Funding and the NIH SBIR Program (2009) National Research Council (NRC) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press, 2009. Please select a format: Page 82   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix D Venture-funded Firms: Data from Hoover’s Small Business Database and VentureSource Company Venture Capital (Thousands of Dollars) Rounds Last Round Date Advanced Tissue Sciences, Inc. 90,578.0 3 11/2/2001 Albion Instruments 8,968.0 7 1/1/1990 Ambion, Inc. 10,500.0 1 5/1/2003 Applied Immune Sciences, Inc. 44,060.1 11 1/1/1991 Applied Molecular Evolution, Inc. 32,350.0 6 6/1/2000 Aronex Pharmaceuticals, Inc. 9,496.0 3 3/2/1999 Aviron (FKA: Vector Pharmaceuticals, Inc.) 87,340.1 4 11/1/2000 Argus Software, Inc. 3,815.9 4 7/30/1999 Aurora Biosciences Corporation 18,720.0 3 12/15/1996 AcryMed, Inc. 3,500.0 4 3/1/2003 Alexion Pharmaceuticals, Inc. 5,800.0 2 12/23/1994 Automatix, Inc. 21,850.0 7 12/1/1987 Aastrom Biosciences, Inc. 36,384.9 8 10/30/2002 ABIOMED, Inc. 35,800.0 1 3/27/2007 Adolor Corporation 137,483.0 7 5/31/2001 Alkermes, Inc. 12,384.3 5 10/1/1992 Amylin Pharmaceuticals, Inc. 84,200.0 9 9/20/2002 ARIAD Pharmaceuticals, Inc. 56,075.0 3 5/20/2003 Aradigm Corporation 139,454.0 9 3/7/2003 Altea Therapeutics 54,546.9 4 6/15/2007 Amedica Corporation 44,569.0 4 4/27/2007 Amnis Corporation 18,750.0 3 3/27/2006 Ancile Pharmaceuticals, Inc. 30,365.0 6 10/27/2002 Page 82 Front Matter (R1-R14) Executive Summary (1-4) 1 Introduction (5-21) 2 Study Methodology (22-29) 3 Venture Funding for NIH Phase II Winners, 1992-2002 (30-38) 4 Focus on the Top 200 Award Winners (39-42) 5 Other Sources of Data on the Participation of Venture-owned Firms (43-48) 6 Comparing Project Outcomes (49-60) 7 Impact of the SBA Ruling on the NIH SBIR Program (61-68) Appendixes (69-70) Appendix A: Venture-funded Firms Among the 200 Most Prolific Winners of NIH Phase II Awards 1992-2002 (71-75) Appendix B: NRC Non-participant Survey (76-79) Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership (80-81) Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource (82-91) Appendix E: Analysis of the Evidence Submitted by BIO (92-94) Appendix F: SBA Administrative Ruling on Appeal of Cognetix, Inc. (95-102) Appendix G: Letter from Elias A. Zerhouni, Director, National Institutes of Health to Hector V. Barreto, Administrator, U.S. Small Business Administration, June 28, 2005 (103-106) Appendix H: Testimony by Steven C. Preston, SBA Administrator, to the House Small Business Committee, March 13, 2008 (107-111) Appendix I: Bibliography (112-126)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 82
Venture Funding and the NIH SBIR Program Appendix D Venture-funded Firms: Data from Hoover’s Small Business Database and VentureSource Company Venture Capital (Thousands of Dollars) Rounds Last Round Date Advanced Tissue Sciences, Inc. 90,578.0 3 11/2/2001 Albion Instruments 8,968.0 7 1/1/1990 Ambion, Inc. 10,500.0 1 5/1/2003 Applied Immune Sciences, Inc. 44,060.1 11 1/1/1991 Applied Molecular Evolution, Inc. 32,350.0 6 6/1/2000 Aronex Pharmaceuticals, Inc. 9,496.0 3 3/2/1999 Aviron (FKA: Vector Pharmaceuticals, Inc.) 87,340.1 4 11/1/2000 Argus Software, Inc. 3,815.9 4 7/30/1999 Aurora Biosciences Corporation 18,720.0 3 12/15/1996 AcryMed, Inc. 3,500.0 4 3/1/2003 Alexion Pharmaceuticals, Inc. 5,800.0 2 12/23/1994 Automatix, Inc. 21,850.0 7 12/1/1987 Aastrom Biosciences, Inc. 36,384.9 8 10/30/2002 ABIOMED, Inc. 35,800.0 1 3/27/2007 Adolor Corporation 137,483.0 7 5/31/2001 Alkermes, Inc. 12,384.3 5 10/1/1992 Amylin Pharmaceuticals, Inc. 84,200.0 9 9/20/2002 ARIAD Pharmaceuticals, Inc. 56,075.0 3 5/20/2003 Aradigm Corporation 139,454.0 9 3/7/2003 Altea Therapeutics 54,546.9 4 6/15/2007 Amedica Corporation 44,569.0 4 4/27/2007 Amnis Corporation 18,750.0 3 3/27/2006 Ancile Pharmaceuticals, Inc. 30,365.0 6 10/27/2002

OCR for page 83
Venture Funding and the NIH SBIR Program First Round Date Status Ticker Symbol Last Known Date Annual Revenue (Millions of Dollars) Number of Employees Profit/Loss 4/1/1996 Out of business   2003       6/1/1986 Sold   2000       5/1/2003 Sold   2006 13.6     11/1/1984 Sold   1995       3/1/1990 Sold     10.2     7/1/1991 Sold   2001       6/1/1992 Sold           1/1/1995 Foreign           3/7/1996 Foreign           4/1/1994 n/a           11/12/1993 NASDAQ ALXN   1.6 241 (131.5) 1/1/1980 n/a           8/18/1989 NASDAQ ASTM   0.7   (17.6) 3/27/2007 NASDAQ AMMD   50.7 324   11/1/1994 NASDAQ ADLR   15.9 179 (69.7) 10/1/1987 NASDAQ alks   240.0 830 9.9 11/1/1987 NASDAQ AMLN   510.9 1,550 (218.9) 2/1/1991 NASDAQ ARIA   0.9 108 (61.9) 10/16/1992 OTC ARDM   4.8 103 (13.0) 11/21/2002 private           1/28/2004 private failed IPO 2007 0.1 33 (6.3) 2/28/2000 private     3.5 37   11/4/1998 private     3.2 30  

OCR for page 84
Venture Funding and the NIH SBIR Program Company Venture Capital (Thousands of Dollars) Rounds Last Round Date Artecel Sciences, Inc. 4,135.2 2 5/29/2002 Atherotech, Inc. 21,399.9 4 1/31/2005 Avocet Medical, Inc. 36,801.0 3 7/1/2001 BioCryst Pharmaceuticals, Inc. 39,964.9 3 9/30/2007 BioMarin Pharmaceutical, Inc. 53,000.0 2 5/16/2001 BIOQUAL, Inc. (FKA: Diagnon Corporation) 1,351.0 2 5/1/1983 Biosearch, Inc. 1,800.0 2 12/1/1983 Biosym Technologies, Inc. 5,168.0 3 4/1/1992 BioTransplant, Inc. 9,561.0 3 6/30/2001 Cambridge Neuroscience, Inc. (FKA: Synax, Inc.) 35,879.0 9 6/21/1997 Cell Based Delivery, Inc. 11,175.0 2 5/7/2002 Centaur Pharmaceuticals, Inc. 63,451.0 7 11/2/2001 Cephalon, Inc. 40,037.8 8 2/25/1999 Chektec Corporation 846.0 3 4/1/1993 Clarus Medical LLC (Medilase, Inc.) 27,548.9 12 5/1/1997 Clontech Laboratories, Inc. 28,836.0 2 7/1/1998 CoCensys, Inc. 24,071.0 9 1/7/1997 Cognetix, Inc. 19,010.0 2 6/1/2006 CompuCyte Corporation 18,700.0 3 8/1/1999 Conductus, Inc. 45,699.9 6 3/27/2002 Control Delivery Systems, Inc. (AKA: CDS, Inc.) 34,500.0 1 8/22/2000 COR Therapeutics, Inc. 20,652.0 6 1/1/1998 Corixa Corporation 157,581.1 6 6/10/2003 Cortex Pharmaceuticals, Inc. 9,100.0 2 7/1/1989 Creative BioMolecules, Inc. 23,284.0 18 7/1/1995 Cryolife, Inc. 3,057.0 3 6/1/1988 Cryopharm Corporation 30,346.0 10 1/1/1994 Cubist Pharmaceuticals, Inc. 36,283.0 5 9/23/1998 CuraGen Corporation 26,790.0 2 9/1/1999 CytoLogix Corporation 46,850.0 5 5/29/2002 Cytomation, Inc. 14,293.0 2 6/8/2001 Cytyc Corporation (FKA: Generitech Corporation) 35,154.9 4 5/1/1995 Dharmacon Research, Inc. 5,700.0 1 8/23/2002 Digirad Corporation (FKA: Aurora Technologies) 75,320.0 9 4/24/2002 DiscoveRx Corporation, Ltd. 28,406.0 5 2/20/2007 Discovery Laboratories, Inc. 13,211.0 2 6/20/2003 Displaytech, Inc. 70,225.1 5 3/12/2006 Edenspace Systems Corporation 5,250.0 1 4/23/2007 EKOS Corporation 85,900.4 8 6/27/2007 Endocyte, Inc. 60,700.2 4 3/23/2007 Epicyte Pharmaceutical, Inc. 22,200.0 4 4/16/2001 EpiGenesis Pharmaceuticals, Inc. 35,956.2 4 3/7/2007 Epoch Biosciences (FKA:MicroProbe Corporation) 30,030.2 13 7/1/1993

OCR for page 85
Venture Funding and the NIH SBIR Program First Round Date Status Ticker Symbol Last Known Date Annual Revenue (Millions of Dollars) Number of Employees Profit/Loss 11/29/2000 private     0.1 1   3/31/1999 private           10/1/1996 private           8/1/1992 NASDAQ     6.2 52 (43.6) 1/1/1998 NASDAQ     84.2 314 (28.5) 7/1/1981 private     19.4 150   4/1/1983 private     4.6 65   10/1/1986 Sold           10/1/1995 Out of business   2003       1/1/1986 Sold           3/7/2002 Out of business           12/1/1992 Out of business   2002       10/1/1987 NASDAQ CEPH   18,641.1 2,895 144.8 12/1/1988 Outof business           1/6/1989 private     0.2 3   7/1/1997 private     17.0 175   2/1/1989 Sold           8/1/2001 Out of business           4/1/1996 private     6.7 28   9/1/1987 Sold           8/22/2000 Sold   2005 17.2 26   3/16/1988 Sold   2002       12/2/1994 Sold   2005       5/1/1988 AMEX COR   1.2 26 (16.2) 5/1/1982 NASDAQ CRIS   16.7 68 (8.8) 1/1/1986 NYSE CRY   81.3 363 0.4 1/1/1988 private     2.5 25   9/1/1992 NASDAQ CBST   194.8 410 (0.4) 3/1/1997 NASDAQ CRGN   39.6 666 (59.8) 1/1/1997 private           5/1/1997 Sold           1/1/1987 Sold   2006 608.0 1,500 139.5 8/23/2002 private     10.1 120   5/30/1995 NASDAQ DRAD   71.9 601 (6.3) 2/1/1999 private     3.3 40   11/5/2002 NASDAQ     0.0 160 (46.3) 4/11/2000 IPO   2002 3.2 47   4/23/2007 private     0.7 10   10/1/1996 private     9.5 99   7/1/2001 private     3.3 40   7/1/1996 Sold   2004       10/1/1997 private           3/1/1986 Sold   2004      

OCR for page 86
Venture Funding and the NIH SBIR Program Company Venture Capital (Thousands of Dollars) Rounds Last Round Date EraGen Biosciences, Inc. (FKA: Sulfonics, Inc.) 32,647.0 3 3/15/2007 Exogene Corporation 7,115.1 5 7/1/1993 Fluorous Technologies, Inc. (AKA: FTI) 3,650.0 2 5/23/2003 Genaera Corporation (FKA: Magainin Pharmaceuticals) 18,106.0 5 10/1/1998 Genaissance Pharmaceuticals, Inc. 75,749.9 4 11/4/2004 Genelabs Technologies, Inc. 34,949.4 8 6/29/2006 GeneMedicine, Inc. 8,900.0 2 7/13/1994 Genetic Therapy, Inc. 13,989.0 8 7/1/1994 GenPharm International, Inc. 18,989.1 8 2/29/2000 Geron Corporation 42,074.8 5 1/1/1996 Gilead Sciences, Inc. 32,060.0 6 8/1/1992 Gliatech, Inc. 32,596.1 7 6/1/1995 Hauser Chemical Research, Inc. 1,893.0 3 12/7/1990 Hawaii Biotech, Inc. 16,500.0 5 12/26/2006 Houston Biotechnology, Inc. 3,240.0 2 5/1/1986 Hypres, Inc. 39,841.0 20 12/31/2002 Icagen, Inc. 96,700.7 7 2/1/2007 Illumigen Biosciences, Inc. 7,950.0 8 7/6/2007 Illumina, Inc. 36,567.0 2 11/1/1999 Immtech Pharmaceuticals, Inc. (FKA: Immtech International) 2,509.0 3 2/14/1994 ImmuLogic Pharmaceutical Corporation 29,844.0 5 2/22/1993 Immunicon Corporation 106,800.4 7 6/29/2005 ImmunoGen, Inc. 21,934.0 7 1/1/1989 Immusol, Inc. 23,500.0 2 9/24/2003 IntraTherapeutics, Inc. (FKA: Cardia Catheter Company) 32,224.2 8 3/31/2000 Invitrogen Corporation 15,000.0 1 6/20/1997 Iomai Corporation 80,570.0 9 10/25/2006 Irvine Sensors Corporation 2,650.0 3 6/10/2003 Isis Pharmaceuticals 17,490.0 6 8/11/1994 Isolab, Inc. 2,744.0 2 6/28/1990 ISTO Technologies, Inc. 25,725.0 5 8/3/2007 Kurzweil Applied Intelligence, Inc. 26,122.1 13 1/1/1993 Large Scale Biology Corp. (FKA: Biosource Genetics Corp) 11,675.1 6 3/1/1998 Laser Diagnostic Technology, Inc. 13,310.9 5 11/30/2001 Laserscope 24,045.4 8 9/1/1987 LeukoSite, Inc. 32,613.1 8 7/1/1998 LifeSpan BioSciences, Inc. 19,000.0 1 4/17/2001 Linguagen Corporation 20,212.0 4 5/23/2006 Lucent Medical Systems, Inc. 6,700.0 2 9/25/1998 Lynx Therapeutics, Inc. 72,200.4 5 9/25/2003 Markwell Medical Institute, Inc. 882.0 5 5/1/1987 MediChem Research Inc. 35,000.0 1 6/28/1999 Medinox, Inc. 21,199.8 2 1/8/2002

OCR for page 87
Venture Funding and the NIH SBIR Program First Round Date Status Ticker Symbol Last Known Date Annual Revenue (Millions of Dollars) Number of Employees Profit/Loss 10/6/2005 private           10/1/1988 Sold   1996       6/20/2000 private     2.0 15   3/1/1988 NASDAQ GENR   0.9 46 (21.2) 8/1/1998 Sold   2005       10/1/1984 NASDAQ GNLB   11.2 66 (8.7) 10/1/1992 private     14.9 110   8/1/1988 private     1.0 15   2/29/2000 Sold           7/10/1992 NASDAQ GERN   3.3 90 (31.4) 8/1/1987 NASDAQ GILD   3,026.1 2,525 (1,190.0) 7/1/1988 Sold   2000       4/1/1988 Out of business           6/7/2002 private     5.1 65   10/1/1985 Sold           7/1/1983 private     8.0 33   10/1/1995 NASDAQ ICGN   8.4 72 (24.8) 5/1/2000 private     1.5 10   11/30/1998 NASDAQ ILMN   184.5 277 40.0 12/21/1992 AMEX IMM   4.3 27 (11.3) 5/1/1987 Out of business   2002       7/1/1988 NASDAQ IMMC   8.7 107 (24.0) 6/1/1981 NASDAQ IMGN   38.2 192 (19.0) 6/1/2001 Sold           10/7/1991 Sold   2001       6/20/1997 NASDAQ     1,263.5 4,835 (191.0) 1/1/1998 NASDAQ IOMI   1.5 66 (31.8) 10/1/1997 NASDAQ IRSN   30.8 166 (8.5) 2/1/1989 NASDAQ ISIS   24.5 258 (45.9) 5/1/1987 Foreign           3/1/2000 private     1.6 24   5/1/1984 private           12/1/1987 private     0.8 20   1/1/1994 Foreign           3/1/1983 Sold   2006       9/1/1994 Sold   1999       4/17/2001 private     3.3 40   12/30/2003 private           7/1/1997 private     0.5 7   2/15/1994 Sold 2007       6/1/1981 Out of business           6/28/1999 private           6/15/1999 private          

OCR for page 88
Venture Funding and the NIH SBIR Program Company Venture Capital (Thousands of Dollars) Rounds Last Round Date MediSpectra, Inc. 58,970.0 8 7/21/2006 Meridian Instruments, Inc. 3,557.0 4 10/1/1993 Message Pharmaceuticals, Inc. 11,142.5 8 4/14/2004 MIICRO, Inc. 6,840.0 4 9/26/2001 MIDI 2.0 8,250 5/3/2004 Moberg Medical, Inc. (AKA: Moberg Research, Inc.) 5,473.8 6 4/1/1997 Molecular Dynamics, Inc. 22,717.0 7 7/1/1994 Myogen, Inc. 191,452.8 6 10/13/2004 Nanosphere, Inc. 80,130.1 5 5/16/2006 NeoGenesis, Inc. 22,999.9 1 6/21/2001 Nereus Pharmaceuticals, Inc. 127,345.6 8 8/9/2007 NeuroControl Corporation 22,800.0 9 1/4/2001 Neurocrine Biosciences, Inc. 21,499.9 6 5/23/1996 Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) 28,717.0 4 12/7/2001 NimbleGen Systems, Inc. 73,250.5 8 1/2/2007 Nimbus Medical, Inc. 9,635.1 3 7/1/1986 Octagen Corporation 4,800.0 2 3/6/2000 Ontogen 24,945.0 5 10/13/2000 Onyx Pharmaceuticals, Inc. 70,200.2 6 5/9/2002 Organ Recovery Systems 13,999.8 1 7/29/2004 Orquest, Inc. 42,814.8 5 10/16/2001 Palatin Technologies 45,700.0 3 1/30/2004 Panacos Pharmaceuticals, Inc. 26,550.0 3 6/28/2007 Perlan Therapeutics, Inc. 5,227.0 3 12/27/2001 Pharmacopeia Drug Discovery, Inc. 8,472.0 1 8/11/2005 PharmaSonics, Inc. 22,700.0 4 6/30/2002 Pharmavene, Inc. 13,044.0 3 6/1/1996 PHT Corporation (AKA: Personal Health Technologies Corp.) 48,250.2 6 10/18/2004 Phylos, Inc. 25,100.0 1 11/30/2000 Physical Optics Corporation 3,337.0 4 8/1/1990 Physical Sciences, Inc. 492.0 2 7/1/1995 Premier Laser Systems, Inc 6,145.0 4 1/1/1997 Progenics Pharmaceuticals, Inc. 21,448.0 2 12/27/2005 Promega Corporation 5,250.0 4 5/27/1993 PRP, Inc. 384.0 2 1/1/1996 Proteome, Inc. 8,100.0 1 12/1/1999 Quantum Dot Corporation (AKA: Q Dot) 39,150.0 3 8/10/2005 Quantum Magnetics, Inc. 3,800.0 3 7/1/1997 Replidyne, Inc. 126,500.1 6 8/17/2005 Repligen Corporation 12,234.0 3 5/1/1985 RiboGene, Inc. (FKA: Transgene) 48,233.2 15 2/1/1997 Sangamo Biosciences 16,950.0 3 12/31/2001 Sangart, Inc. 50,353.0 2 4/4/2007

OCR for page 89
Venture Funding and the NIH SBIR Program First Round Date Status Ticker Symbol Last Known Date Annual Revenue (Millions of Dollars) Number of Employees Profit/Loss 6/1/1996 private     1.6 21   5/1/1983 Sold           1/1/1998 Out of business   2004       10/31/1997 private     1.6 20   5/19/2005 private     1.3 25   1/1/1992 private           9/1/1987 Sold   1998       10/5/1998 Sold   2006       1/25/2000 NASDAQ NSPH   1.1 50 113.0 1/9/2001 Sold   2005       7/29/1998 private     9.3 29   3/3/1994 private           9/25/1992 NASDAQ NBIX   39.2 588 (107.2) 10/1/1998 private           9/1/2000 Sold           3/1/1988 Sold   1996       4/1/1998 private           5/19/1992 Out of business   2003       4/24/1992 NASDAQ     0.3 125 (92.7) 1/20/2003 private     2.4 27   6/8/1994 Sold   2003       11/1/1996 AMEX PTN   14.4 85 (27.8) 11/4/2000 NASDAQ PANC   0.3 32 (38.1) 6/4/1999 private     1.2 14   8/11/2005 NASDAQ PCOP   16.9 150 (27.8) 2/1/1997 Out of business           4/1/1993 Sold           11/3/1999 private     8.4 80   11/30/2000 private     1.7 18   8/1/1987 private     30.0 150   5/9/1995 private     12.4 150   4/1/1994 Out of business           12/1/1995 NASDAQ PGNX   69.9 149 (21.6) 10/1/1982 private     175.0 850   4/1/1996 private     6.8 130   12/1/1999 private           1/1/1999 Sold   2005       10/15/1995 Out of business           2/21/2002 NASDAQ RDYN   16.0 85 (29.3) 11/1/1981 NASDAQ RGEN   14.1 45 (0.9) 1/1/1990 Sold   1999       6/1/1996 NASDAQ SGMO   7.9 62 (17.9) 10/31/2004 private     7.3 35  

OCR for page 90
Venture Funding and the NIH SBIR Program Company Venture Capital (Thousands of Dollars) Rounds Last Round Date Scios Nova, Inc. (F.K.A Scios Inc) California Biotechnology) 5,425.0 1 6/1/1982 Secretech 800.0 2 10/1/1990 Selective Genetics, Inc. (FKA: Prizm Pharmaceuticals, Inc.) 56,867.0 14 12/1/2003 Sepracor, Inc. 16,892.0 8 2/22/1993 Signal Pharmaceuticals, Inc. 44,543.7 10 12/1/1999 Spire Corporation 3,750.0 3 1/1/1987 Stratagene Cloning Systems 1,873.0 2 12/31/1992 Structural Bioinformatics, Inc. 46,371.7 4 3/22/2000 Sunesis Pharmaceuticals, Inc. (FKA: Mosaic Pharmaceutical) 163,338.1 8 5/30/2007 Synaptic Pharmaceutical Corporation (FKA:Neurogenetic Corp) 89,772.2 7 9/5/2001 T Cell Sciences, Inc. 3,634.0 3 10/1/1989 Targeted Genetics Corporation 46,450.0 4 6/28/2007 TechniScan Medical Systems, Inc. 6,400.0 1 2/5/2007 Tegic Communications, Inc. (AKA:T9 Text Input) 15,000.0 2 5/4/1999 Telefactor Corporation 450.0 3 12/31/1998 Telios Pharmaceuticals, Inc. 30,530.0 7 1/1/1993 Third Wave Technologies, Inc. 78,064.2 5 7/26/2000 TraceDetect, Inc. 1,600.0 2 11/17/2003 TransMolecular, Inc. 42,364.3 4 2/20/2004 Trimeris, Inc. (FKA: SL-1 Pharmaceuticals, Inc.) 38,283.0 6 9/1/1999 United Biomedical, Inc. 9,000.0 1 7/1/1997 UroCor, Inc. (FKA: CytoDiagnostics, Inc.) 16,600.1 5 7/1/1995 VaxGen, Inc. 29,449.0 2 3/1/1997 Vertex Pharmaceuticals, Inc. 13,538.0 5 10/1/1996 VueSonix Sensors 4,600.0 3 7/30/2004 Xeotron Corporation 9,000.0 1 5/1/2001 Xeyex Corporation 3,267.0 2 6/30/1999 Zynaxis, Inc.(FKA: Zynaxis Cell Science/PKH Labs) 37,581.0 8 1/1/1995 Martek Biosciences Corporation 35,167.1 8 1/1/1986 Vestar, Inc. 34,509.1 15 7/1/1981 Vical, Inc. 17,850.0 7 6/1/1987 NOTE: Hoover’s data reflect current data available through Hoover’s Small Business Database as of September 2007. SOURCES: Data on VC investments are from VentureSource; data on current and historical firms status are from Hoover’s Small Business Database (<http://www.hoovers.com>).

OCR for page 91
Venture Funding and the NIH SBIR Program First Round Date Status Ticker Symbol Last Known Date Annual Revenue (Millions of Dollars) Number of Employees Profit/Loss 6/1/1982 Sold           9/1/1989 Out of business           6/12/1992 private           1/1/1984 NASDAQ SEPR   1,196.5 228 184.6 1/1/1993 private     48.5 134   11/1/1979 NASDAQ SPIR   20.1 118 (8.1) 4/1/1987 Sold           11/1/1996 Sold           2/17/1998 NASDAQ SNSS   13.7 138   1/1/1987 Sold           4/1/1985 Out of business           6/1/1992 NASDAQ TGEN   9.9 95 (34.0) 2/5/2007 private           1/22/1998 Sold           12/31/1997 Sold   2000       1/1/1986 Sold           6/30/1995 NASDAQ TWTI   28.0 154 (18.9) 3/15/2002 private     1.4 12   9/30/1997 private     1.2 18   2/12/1993 NASDAQ TRMS   37.0 90 7.4 7/1/1997 private     13.8 285   7/1/1987 Sold           4/10/1996 private           1/1/1989 NASDAQ TRTX   216.4 320 (206.9) 6/9/2000 private           5/1/2001 Sold   2004       1/1/1997 Out of business           6/1/1988 Out of business           2/1/2005 NASDAQ MATK   270.0 582 14.9 7/1/1993 Out of business   2000       3/10/1993 NASDAQ VICL   14.7 155 (23.1)